← Browse by Condition
Medical Condition

moderate hepatic impairment

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06962332 Phase 1
Recruiting

Pharmacokinetics (PK) and Safety of Zanzalintinib in Participants With Moderate Hepatic Impairment (HI)

Enrollment
20 pts
Location
United States
Sponsor
Exelixis
View Trial →